Momentis Surgical

Summary

About

About Momentis Surgical

Momentis Surgical develops the Anovo Surgical System, a compact robotic platform for minimally invasive procedures. The architecture uses instrument arms with shoulder, elbow and wrist joints, a 13-pound robotic control unit mounted at the operating table and an open console that preserves direct communication between the surgeon and operating-room team.

The US Food and Drug Administration granted De Novo marketing authorization in February 2021 for specified single-site, natural-orifice laparoscopic-assisted transvaginal benign procedures in adults. Momentis subsequently placed systems with US hospitals, including an acquisition by HCA Florida Northwest Hospital announced in October 2022. Supported procedures remain limited to the authorized indications and trained clinical use.

PRICE
Range 1Y
Return
High
Low
Updated

Products

Team

  • Dvir Cohen - Co-founder and Chief Executive Officer - Leads development and commercial adoption of the Anovo surgical system.

Timeline

Events

Context

Comparable profiles

Shared workflows

Context tags

  • Single-port surgical robotics - Peer Group - https://www.momentissurgical.com/anovo-surgical-system/ - the Anovo system is a single-port robotic platform delivering multi-arm instruments through one natural-orifice access…
  • Robot-assisted procedure workflow - Workflow - https://www.momentissurgical.com/ - Momentis develops robotic systems and instruments for robot-assisted surgery.
  • Flexible endoluminal navigation - Capability - https://www.momentissurgical.com/anovo-surgical-system/ - the system navigates flexible anatomical pathways for transvaginal procedures.